http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 11 Aug 2026 17:21:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Aug+07/26907137.html si-local-file:///var/storage/secattach/20260811/26907137.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Aug+07/26907137.html Tue, 11 Aug 2026 17:21:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Aug+07/26907137.html si-local-file:///var/storage/secattach/20260811/26907137.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Aug+07/26907137.html Tue, 11 Aug 2026 17:21:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26902236.html si-local-file:///var/storage/secattach/20260811/26902236.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26902236.html Tue, 11 Aug 2026 08:44:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26902236.html si-local-file:///var/storage/secattach/20260811/26902236.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26902236.html Tue, 11 Aug 2026 08:44:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++DEF+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26900721.html si-local-file:///var/storage/secattach/20260811/26900721.html http://www.streetinsider.com/SEC+Filings/Form++DEF+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26900721.html Tue, 11 Aug 2026 06:08:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++DEF+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26900721.html si-local-file:///var/storage/secattach/20260811/26900721.html http://www.streetinsider.com/SEC+Filings/Form++DEF+14C++++CLEARONE+INC++++++++++++++For%3A+Aug+11/26900721.html Tue, 11 Aug 2026 06:08:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CLEARONE+INC+++++++++++++++++++++++++/26898821.html si-local-file:///var/storage/secattach/20260810/26898821.html http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CLEARONE+INC+++++++++++++++++++++++++/26898821.html Mon, 10 Aug 2026 16:48:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CLEARONE+INC+++++++++++++++++++++++++/26898821.html si-local-file:///var/storage/secattach/20260810/26898821.html http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CLEARONE+INC+++++++++++++++++++++++++/26898821.html Mon, 10 Aug 2026 16:48:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CLEARONE+INC++++++++++++++For%3A+Aug+04++Filed+by%3A+HROMYK+ANDREW/26886021.html si-local-file:///var/storage/secattach/20260806/26886021.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CLEARONE+INC++++++++++++++For%3A+Aug+04++Filed+by%3A+HROMYK+ANDREW/26886021.html Thu, 06 Aug 2026 19:44:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CLEARONE+INC++++++++++++++For%3A+Aug+04++Filed+by%3A+HROMYK+ANDREW/26886021.html si-local-file:///var/storage/secattach/20260806/26886021.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CLEARONE+INC++++++++++++++For%3A+Aug+04++Filed+by%3A+HROMYK+ANDREW/26886021.html Thu, 06 Aug 2026 19:44:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CLEARONE+INC+++++++++++++++++++++++++++Filed+by%3A+First+Finance+Ltd./26885790.html si-local-file:///var/storage/secattach/20260806/26885790.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CLEARONE+INC+++++++++++++++++++++++++++Filed+by%3A+First+Finance+Ltd./26885790.html Thu, 06 Aug 2026 17:52:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CLEARONE+INC+++++++++++++++++++++++++++Filed+by%3A+First+Finance+Ltd./26885790.html si-local-file:///var/storage/secattach/20260806/26885790.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CLEARONE+INC+++++++++++++++++++++++++++Filed+by%3A+First+Finance+Ltd./26885790.html Thu, 06 Aug 2026 17:52:00 -0400 CLRO O.00075825 http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Press+Releases/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html <p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) --  (<a href="https://www.globenewswire.com/Tracker?data=2GbADOnMjmzSf5VQGjoz7kbTsY9OnpF4dPeV8nA5eJYQ3mbKEyJSv9-CZ-OSfTZ_It-wQI_Mmv-GNHGypvAGbwYToInPjVbYNVGZ1fLaTjo=" rel="nofollow" target="_blank">https://247mnn.com/</a>) – <a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPgv5XUqXDoUzAh9CeeCR4di67fv-VIVWUy7GOKHiciYMYD3t1ed6DBp-dZ97ouMNnwyJRXGH_rEN9ejoXN0n8OE=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (NASDAQ: CLRO)</strong>, <a href="https://www.globenewswire.com/Tracker?data=krJXO7IpdzzVEVfXK6RlvtuRSnL8QgfC4S3ReJoLUjFaEzYW6ZJK9Pwv5qhzDXOLqIMd06Xwjt0JApaoqK4ADoOjIBBQYyhif7OTJISTBSq7LEQdb9KY-SqtsfJRyDUd" rel="nofollow" target="_blank"><strong><u>NeOnc Technologies</u></strong></a><strong> (NASDAQ: NTHI)</strong>, <a href="https://www.globenewswire.com/Tracker?data=HTGtEfPCFtcixTYemLTJ1i4zx2ybZu5wb4H2OmHwbxIY8I_wbJL1QvQhSHeqvoJ-16bR6_ca36jMMyxCfO6bItXNiyi-dnvjQG4B2iiCL4F08x3oVcirV-ZXmZA8xckK" rel="nofollow" target="_blank"><strong>Iovance Biotherapeutics</strong></a><strong> (NASDAQ:IOVA)</strong>, and <a href="https://www.globenewswire.com/Tracker?data=vf1KrJ2dmXGJeQfqTKzXsAA7qYdEd11M4MmhDSHIVi-hNI3Xrh71SdMmtJwooBzF9xbIL6xTcXaMTneJbwEtP4m0jD2D3K3oH4KfM2ZEAAT4JEhiBLXUtbnjNJj6BfSP" rel="nofollow" target="_blank"><strong>Ensysce Biosciences</strong></a><strong> (NASDAQ:ENSC)</strong> are covered in today’s roundup.</p> <p><strong>ClearOne Advances Toward Neurotechnology Transformation</strong></p> <p><a href="https://www.globenewswire.com/Tracker?data=xuxUDRZCTy-tT5z-YIYWPiBL0vSYzH9IL68g_JoJdbjNL3YHETgdvlYAQmFJ0jrmj2jycvgrINhlzXWG5MSC61jG7_ZRzIV89zlw_4YCEbc=" rel="nofollow" target="_blank"><strong>ClearOne</strong></a><strong> (</strong><strong>NASDAQ:CLRO</strong><strong>)</strong> continues moving closer to completing its planned transformation into a neurotechnology company as new SEC filings remove several key uncertainties surrounding its pending acquisition of Cortigent, a wholly owned subsidiary of <strong>Vivani Medical (</strong><strong>NASDAQ:VANI</strong><strong>)</strong>, which was first announced on July 2, as investors http://www.streetinsider.com/Globe+Newswire/Why+Investors+Are+Watching+These+Healthcare+Movers/26882092.html Thu, 06 Aug 2026 12:31:07 -0400 CLRO ENSC IOVA NTHI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Jul+31/26875650.html si-local-file:///var/storage/secattach/20260805/26875650.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Jul+31/26875650.html Wed, 05 Aug 2026 17:01:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Jul+31/26875650.html si-local-file:///var/storage/secattach/20260805/26875650.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Jul+31/26875650.html Wed, 05 Aug 2026 17:01:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Jul+17/26785223.html si-local-file:///var/storage/secattach/20260717/26785223.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Jul+17/26785223.html Fri, 17 Jul 2026 17:23:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Jul+17/26785223.html si-local-file:///var/storage/secattach/20260717/26785223.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14C++++CLEARONE+INC++++++++++++++For%3A+Jul+17/26785223.html Fri, 17 Jul 2026 17:23:00 -0400 CLRO O.00075825 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Jul+06/26735997.html si-local-file:///var/storage/secattach/20260706/26735997.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CLEARONE+INC++++++++++++++For%3A+Jul+06/26735997.html Mon, 06 Jul 2026 16:31:00 -0400 CLRO O.00075825